One last chance to register for the premier metrology event in 2024

ZEISS QUALITY INNOVATION SUMMIT.

From lab to patient – the art of developing new antibody therapies

For 25 years, Danish company Genmab has been developing antibodies and has managed to get several drugs all the way to the patient. Esther Breij has been along ...

Save the dates: ZEISS Quality Innovation Summit, October 22-24

Embark on a journey to the future of metrology.

Column: ”Authentic leadership and clear mandates pave the way for more female CEOs”

”I believe that the aspect of having clear mandates and titles on the one hand and women progressing into top positions must be explored further”, Helena Strigå...

Sobi announces agreement with Enable Injections

Swedish biopharma Sobi has entered into an international development and distribution agreement with US drug delivery company Enable Injections.

ZEISS Microscope has been Optimized for Capturing Subcellular Structures and their Dynamics

Live imaging with uniform super-resolution in all spatial dimensions.

Eli Lilly förvärvar Siteone – får tillgång till smärtkandidat

Eli Lilly planerar att förvärva biopharmabolaget Siteone Therapeutics, vilket bedöms stärka den amerikanska läkemedelsjättens satsningen på att utveckla icke-op...

A surprising discovery about the immune system in cases of cancer

Professor Göran Jönsson is trying to understand why some patients benefit from immunotherapies while others don’t. A couple of years ago, he made a surprising d...

Jazz anklagas för falskspel – går med på förlikning

Irländska Jazz Pharmaceuticals har gått med på att betala 145 miljoner dollar i förlikning efter anklagelser om brott mot amerikanska konkurrenslagar.

Takeover bid is being completed – Japanese company acquires Calliditas

Japanese company Asahi Kasei completes the bid for Calliditas Therapeutics after reaching over 90 percent of the shareholding. Callidita's board has now decided...

Bolag tiodubblade läkemedelpris – döms till miljardböter

En brittisk appellationsdomstol har fastställt en bötessumma på 99 miljoner pund, motsvarande nästan 1,3 miljarder kronor, för ägarna av läkemedelsbolaget Advan...

Artificial intelligence in radiology – “Risk prediction is very exciting”

A growing number of solutions based on artificial intelligence are being developed and used in healthcare. According to Sophia Zackrisson, Professor of Radiolog...

SupraCube - In life Science

Superconductors must be permanently kept below their transition temperature for levitation. Because of the integrated cooler, applications with superconductors ...

TFS Trial Form Support AB

Medical device quality assurance

Recordings from ZEISS Quality Innovation Days.

Amrop Malmö AB

Acquisition of consulting company Key2Compliance

The Swedish company Key2Compliance, offering services in fields such as pharma and Medtech, has been acquired by German GBA Group.

Fundamental Aspects of Airy Disk Patterns

Knowledge Article from ZEISS.

Proaktiv övervakning och läckagetest av värmeväxlare

Maximera drifttid och resursutnyttjande i produktionen.

Norge nobbar nationell life science-strategi – ser inget behov

Norska Arbeiderpartiet avvisar ett förslag om att Norge bör ta fram en egen life science-strategi.

Studie: Upptäckt om tarmceller ger hopp om att bromsa Crohns sjukdom

Forskare vid Göteborgs universitet har upptäckt ett nytt sätt att angripa Crohns sjukdom. Det handlar om att reparera tarmcellernas skyddsbarriär för att behandla sjukdomen.

Christina Lloyd: ”Vi måste koppla kvinnohälsa till ledarskap”

Nätverket Vilda, som verkar för att stärka kvinnligt ledarskap och främja jämställdhet inom life science, har på kort tid vuxit i medlemsantal. Nu är siktet ins...

The physician at the tech giant: “Observations in the emergency room made my mind up”

When Nasim Farrokhnia was in third grade at school in Tehran, the capital of Iran, her father gave her a book about Marie Curie, which soon became her favourite...

BioArctic moves forward with its candidate for Parkinson’s

BioArctic announces positive early phase study results for its drug candidate for Parkinson’s disease.